[Federal Register Volume 64, Number 41 (Wednesday, March 3, 1999)]
[Notices]
[Page 10334]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5197]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes on March 24-
25, 1999. The meeting will take place at the address provided below. 
Topics of discussion will include revisions to proposed 10 CFR Part 35, 
``Medical Use of Byproduct Material''; analysis of comments on the 
draft rule text that were received during the public comment period; 
and issues associated with prostate implant therapy. All sessions of 
the meeting will be open to the public with the exception of the first 
session, which has been set aside to provide required Annual Ethics 
Training for committee members. This session will be closed to discuss 
information, the release of which would constitute a clearly 
unwarranted invasion of personal privacy.

DATES: The March 24, 1999, meeting will be held from 9:00 a.m. to 5:00 
p.m. to accommodate Annual Ethics Training for members from 8:00 to 
9:00 a.m. The March 25, 1999, meeting will be held from 8:00 a.m. to 
12:00 p.m.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North 
Auditorium, 11545 Rockville Pike, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION, CONTACT: Mary Louise Roe, U.S. Nuclear 
Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards, MS T9F31, Washington, DC 20555, Telephone (301) 415-7809, 
e-mail [email protected].

Conduct of the Meeting

    Judith Stitt, M.D., will chair the meeting. Dr. Stitt will conduct 
the meeting in a manner that will facilitate the orderly conduct of 
business. The following procedures apply to public participation in the 
meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Mary Louise Roe (address listed previously), by 
March 19, 1999. Statements must pertain to the topics on the agenda for 
the meeting. Electronic submissions may be sent to [email protected].
    2. Questions from members of the public will be permitted, during 
the meeting, at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection, and copying, for a fee, at the NRC Public Document Room, 
2120 L Street, NW, Lower Level, Washington, DC 20003-1527, telephone 
(202) 634-3273, on or about April 19, 1999. Minutes of the meeting will 
be available on or about May 18, 1999.
    4. Seating for the public will be on a first-come, first-served 
basis.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: February 25, 1999.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 99-5197 Filed 3-2-99; 8:45 am]
BILLING CODE 7590-01-P